NCT02162355 - Multiple Ascending Dose Study of GLPG0634 in Japanese and Caucasian Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

GLPG0634 50 mg

2 tablets of 25 mg GLPG0634 once daily for 10 days

DRUG

GLPG0634 100 mg

1 tablet of 100 mg GLPG0634 once daily for 10 days

DRUG

GLPG0634 200 mg

2 tablets of 100 mg GLPG0634 once daily for 10 days

DRUG

Placebo

1 or 2 matching placebo tablets once daily for 10 days

Trial Locations (1)

Hammersmith Medicines Research (HMR), London